$11.00
In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

Composition:


active ingredient: 1 tablet contains chlorophyllipt extract thick (10.76:1) (extractant ethanol 93 %) – 12.5 mg or 25 mg;


excipients: sugar, ascorbic acid, calcium stearate.


Dosage form. Pills.


Basic physical and chemical properties: tablets from light green to green color with inclusions, flat-cylindrical, with a risk and chamfer, with a specific smell.


Pharmacotherapeutic group. Medications used for throat diseases. Antiseptics. ATX code R02A A20.


Pharmacological properties.


Pharmacodynamics.


Chlorophyllipt is a mixture of chlorophylls from eucalyptus leaves. The drug has an antibacterial (bacteriostatic and bactericidal) effect against staphylococci, as well as antiseptic and anti-inflammatory effects.


Pharmacokinetics.


Not investigated.


Clinical characteristics.


Indications. Diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis), as well as aphthous and ulcerative stomatitis.


Contraindications. Hypersensitivity to chlorophyllipt or other components of the drug.


Interactions with other drugs and other types of interactions. Enhances the effect of antiseptic drugs.


Application features. Before starting use, you should consult your doctor.


After the first application, you should pause for 6-8 hours. Course treatment with the drug is possible after confirming the absence of an allergic reaction to chlorophyllipt thick extract (the probability of swelling of the lips, nasal mucosa, pharynx and other allergic reactions). If any of these symptoms occur, the drug should be discontinued and a doctor should be consulted.


If the patient is found to be intolerant to certain sugars, you should consult your doctor before taking this medicine.


Use during pregnancy or lactation. The efficacy and safety of the drug during pregnancy or lactation have not been studied, so the drug should not be used in this category of patients.


Ability to influence the reaction rate when driving vehicles or other mechanisms. Not investigated.


Dosage and administration. Adults should be prescribed tablets of 12.5 mg or 25 mg, depending on the severity of the pathological process. Do not swallow or chew the tablet, but keep it in your mouth until it is completely absorbed. The daily dose for adults is 25 mg 5 times a day. The frequency of administration is 1 tablet (12.5 mg or 25 mg) every 4-5 hours. The course of treatment is 7 days.


Children. There is no experience of using the drug in children.


Overdose. Possible increase in adverse reactions.


Adverse reactions.


Immune system disorders: allergic reactions, including rash, pruritus, angioedema, hyperemia.


From the digestive tract: irritation of the oral mucosa, nausea, vomiting.


Nervous system disorders: headache, dizziness.


Expiration date. 3 years.


Storage conditions. At a temperature not exceeding 25 °C in the original packaging.


Keep out of reach of children.

Tags: Butamirat